Satellos Bioscience Inc. (MSCL) — Strategic Asset Allocation Index
Satellos Bioscience Inc. (MSCL) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of CA$5.00K plus long-term investments of CA$0.00) total CA$5.00K, measured against net assets of CA$27.73 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Satellos Bioscience Inc. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Satellos Bioscience Inc. Strategic Asset Allocation Index (2021–2025)
This chart shows how Satellos Bioscience Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of CA$5.00K against net assets of CA$27.73 Million CAD. For live market cap and overall valuation, see Satellos Bioscience Inc. (MSCL) market capitalisation.
Annual Strategic Asset Allocation Index for Satellos Bioscience Inc. (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Satellos Bioscience Inc. from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Satellos Bioscience Inc. for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | CA$5.00K | CA$5.00K | CA$0.00 | CA$27.73 Million | ▲ +0.0 pp |
| 2024 | 0.0% | CA$4.00K | CA$4.00K | CA$0.00 | CA$67.86 Million | ▼ -0.1 pp |
| 2023 | 0.1% | CA$44.73K | CA$13.82K | CA$30.91K | CA$40.67 Million | ▼ -1.0 pp |
| 2022 | 1.1% | CA$36.79K | CA$5.85K | CA$30.95K | CA$3.37 Million | ▲ +1.1 pp |
| 2021 | 0.0% | CA$0.00 | CA$- | CA$0.00 | CA$10.48 Million | — |